Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/38837
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThouvenin, J.-
dc.contributor.authorVan Marcke, C.-
dc.contributor.authorDecoster, L.-
dc.contributor.authorRaicevic, G.-
dc.contributor.authorPunie, K.-
dc.contributor.authorVandenbulcke, M.-
dc.contributor.authorSalgado, R.-
dc.contributor.authorVan Valckenborgh, E.-
dc.contributor.authorMaes, B.-
dc.contributor.authorJoris, S.-
dc.contributor.authorVander Steichel, D.-
dc.contributor.authorVranken, K.-
dc.contributor.authorJacobs , S.-
dc.contributor.authorDedeurwaerdere, F.-
dc.contributor.authorMartens, G.-
dc.contributor.authorDevos, H.-
dc.contributor.authorDuhoux, F. P.-
dc.contributor.authorRasschaert, M.-
dc.contributor.authorPauwels , P.-
dc.contributor.authorGeboes, K.-
dc.contributor.authorCollignon, J.-
dc.contributor.authorTejpar, S.-
dc.contributor.authorCanon, J-L-
dc.contributor.authorPeeters, M.-
dc.contributor.authorRutten, A.-
dc.contributor.authorVan de Mooter, T.-
dc.contributor.authorVermeij, J.-
dc.contributor.authorSchrijvers, D.-
dc.contributor.authorDemey, W.-
dc.contributor.authorLybaert, W.-
dc.contributor.authorVan Huysse, J.-
dc.contributor.authorMEBIS, Jeroen-
dc.contributor.authorAwada, A.-
dc.contributor.authorClaes, K. B. M.-
dc.contributor.authorHebrant, A.-
dc.contributor.authorVan der Meulen, J.-
dc.contributor.authorDelafontaine, B.-
dc.contributor.authorVanden Bempt, I-
dc.contributor.authorMaetens, J.-
dc.contributor.authorde Hemptinne, M.-
dc.contributor.authorRottey, S.-
dc.contributor.authorAftimos, P.-
dc.contributor.authorDe Greve, J.-
dc.date.accessioned2022-11-07T09:17:30Z-
dc.date.available2022-11-07T09:17:30Z-
dc.date.issued2022-
dc.date.submitted2022-10-20T13:02:58Z-
dc.identifier.citationESMO Open, 7 (4)-
dc.identifier.urihttp://hdl.handle.net/1942/38837-
dc.description.abstractPRECISION is an initiative from the Belgian Society of Medical Oncology (BSMO) in collaboration with several stakeholders, encompassing four programs that aim to boost genomic and clinical knowledge with the ultimate goal to offer patients with metastatic solid tumors molecularly guided treatments. The PRECISION 1 study has led to the creation of a clinico-genomic database. The Belgian Approach for Local Laboratory Extensive Tumor Testing (BALLETT) and GeNeo studies will increase the number of patients with advanced cancer that have comprehensive genotyping of their cancer. The PRECISION 2 project consists of investigator-initiated phase II studies aiming to provide access to a targeted drug for patients whose tumors harbor actionable mutations in case the matched drug is not available through reimbursement or clinical trials in Belgium.-
dc.description.sponsorshipThis work was supported by grants from the 1 study and grants from the Belgian Foundation against Cancer and Kom op Tegen Kanker to the PRECISION 1 and 2 studies and the Biltema Foundation (no grant number). GeNeo is funded by a grant from Roche (no grant number). BALLETT is funded by grants from Illumina and OncoDNA (no grant number).-
dc.language.isoen-
dc.publisherELSEVIER-
dc.rights2022 Published by Elsevier Ltd on behalf of European Society for Medical Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).-
dc.subject.othernext-generation sequencing (NGS)-
dc.subject.othermetastatic tumors-
dc.subject.othergenomic alterations genomic-driven therapy-
dc.subject.othergenomic-driven therapy-
dc.subject.othermolecular tumor board-
dc.titlePRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment-
dc.typeJournal Contribution-
dc.identifier.issue4-
dc.identifier.volume7-
local.bibliographicCitation.jcatA1-
dc.description.notesDe Greve, J (corresponding author), Vrije Univ Brussel, UZBrussel, Dept Med Genet, Laarbeeklaan 101, B-1090 Jette, Belgium.-
dc.description.notesJacques.degreve@uzbrussel.be-
local.publisher.placeRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1016/j.esmoop.2022.100524-
dc.identifier.pmid35970014-
dc.identifier.isi000861050700001-
dc.contributor.orcid/0000-0003-3281-8643; Dedeurwaerdere, Franceska/0000-0003-4608-1101-
local.provider.typewosris-
local.description.affiliation[Thouvenin, J.] Hosp Civils Lyon, Med Oncol, Lyon, France.-
local.description.affiliation[Thouvenin, J.] Med Oncol Clin, Inst Jules Bordet, Brussels, Belgium.-
local.description.affiliation[Van Marcke, C.; Duhoux, F. P.] UCLouvain, Ottignies, Belgium.-
local.description.affiliation[Decoster, L.; Joris, S.; De Greve, J.] UZ Brussel, Med Oncol, Brussels, Belgium.-
local.description.affiliation[Raicevic, G.; Vandenbulcke, M.; Van Valckenborgh, E.; Hebrant, A.; Maetens, J.; de Hemptinne, M.] Sciensano, Brussels, Belgium.-
local.description.affiliation[Punie, K.] Katholieke Univ Leuven, Univ Hosp Leuven, Gen Med Oncol, Leuven, Belgium.-
local.description.affiliation[Salgado, R.] GasthuisZusters Antwerpen, Pathol, Antwerp, Belgium.-
local.description.affiliation[Maes, B.; Mebis, J.] Jessa Hosp Campus Virga Jesse, Lab Mol Diagnost, Hasselt, Belgium.-
local.description.affiliation[Vander Steichel, D.] Fdn Canc, Schaerbeek, Belgium.-
local.description.affiliation[Vranken, K.] WIV ISP, Pediat Oncol, Leuven, Belgium.-
local.description.affiliation[Jacobs, S.; Tejpar, S.; Vanden Bempt, I] KU Leuven Hosp, Leuven, Belgium.-
local.description.affiliation[Dedeurwaerdere, F.] AZ Delta, Lab Pathol, Roeselare, Belgium.-
local.description.affiliation[Martens, G.] AZ Delta, Lab Geneeskunde, Roeselare, Belgium.-
local.description.affiliation[Devos, H.] Acad Hosp St Jan, Lab Geneeskunde, Brugge, Belgium.-
local.description.affiliation[Rasschaert, M.] Univ Ziekenhuis Antwerpen, Med Oncol, Antwerp, Belgium.-
local.description.affiliation[Rasschaert, M.] AZ Mon, Med Oncol, Deurne, Netherlands.-
local.description.affiliation[Pauwels, P.] Univ Ziekenhuis Antwerpen, Pathol, Antwerp, Belgium.-
local.description.affiliation[Geboes, K.] UZ Gent, Dept Gastroenterol, Div Digest Oncol, Ghent, Belgium.-
local.description.affiliation[Geboes, K.] UZ Gent, Dept Internal Med & Pediat, Ghent, Belgium.-
local.description.affiliation[Collignon, J.] CHU Liege Hosp Sart Tilman, Med Oncol, Liege, Belgium.-
local.description.affiliation[Canon, J-L] Grand Hop Charleroi Site Notre Dame, Serv Oncol Hematol, Charleroi, Belgium.-
local.description.affiliation[Peeters, M.] Univ Ziekenhuis Antwerpen, Oncol, Antwerp, Belgium.-
local.description.affiliation[Rutten, A.; Van de Mooter, T.; Lybaert, W.] GZA Ziekenhuizen Campus Sint Vincentius, Med Oncol, Antwerp, Belgium.-
local.description.affiliation[Vermeij, J.] ZNA Middelheim, Med Oncol, Antwerp, Belgium.-
local.description.affiliation[Schrijvers, D.] ZNA, Antwerp, Belgium.-
local.description.affiliation[Demey, W.] AZ Klina, Med Oncol, Brasschaat, Belgium.-
local.description.affiliation[Van Huysse, J.] AZ Sint Jan Brugge Oostende, Pathol, Brugge, Belgium.-
local.description.affiliation[Awada, A.; Aftimos, P.] Inst Jules Bordet, Med Oncol Clin, Anderlecht, Belgium.-
local.description.affiliation[Claes, K. B. M.; Van der Meulen, J.] UGent, Ghent, Belgium.-
local.description.affiliation[Delafontaine, B.] UZ Gent, Ghent, Belgium.-
local.description.affiliation[Rottey, S.] UZ Gent, Med Oncol Dept, Ghent, Belgium.-
local.uhasselt.internationalyes-
item.fullcitationThouvenin, J.; Van Marcke, C.; Decoster, L.; Raicevic, G.; Punie, K.; Vandenbulcke, M.; Salgado, R.; Van Valckenborgh, E.; Maes, B.; Joris, S.; Vander Steichel, D.; Vranken, K.; Jacobs , S.; Dedeurwaerdere, F.; Martens, G.; Devos, H.; Duhoux, F. P.; Rasschaert, M.; Pauwels , P.; Geboes, K.; Collignon, J.; Tejpar, S.; Canon, J-L; Peeters, M.; Rutten, A.; Van de Mooter, T.; Vermeij, J.; Schrijvers, D.; Demey, W.; Lybaert, W.; Van Huysse, J.; MEBIS, Jeroen; Awada, A.; Claes, K. B. M.; Hebrant, A.; Van der Meulen, J.; Delafontaine, B.; Vanden Bempt, I; Maetens, J.; de Hemptinne, M.; Rottey, S.; Aftimos, P. & De Greve, J. (2022) PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment. In: ESMO Open, 7 (4).-
item.contributorThouvenin, J.-
item.contributorVan Marcke, C.-
item.contributorDecoster, L.-
item.contributorRaicevic, G.-
item.contributorPunie, K.-
item.contributorVandenbulcke, M.-
item.contributorSalgado, R.-
item.contributorVan Valckenborgh, E.-
item.contributorMaes, B.-
item.contributorJoris, S.-
item.contributorVander Steichel, D.-
item.contributorVranken, K.-
item.contributorJacobs , S.-
item.contributorDedeurwaerdere, F.-
item.contributorMartens, G.-
item.contributorDevos, H.-
item.contributorDuhoux, F. P.-
item.contributorRasschaert, M.-
item.contributorPauwels , P.-
item.contributorGeboes, K.-
item.contributorCollignon, J.-
item.contributorTejpar, S.-
item.contributorCanon, J-L-
item.contributorPeeters, M.-
item.contributorRutten, A.-
item.contributorVan de Mooter, T.-
item.contributorVermeij, J.-
item.contributorSchrijvers, D.-
item.contributorDemey, W.-
item.contributorLybaert, W.-
item.contributorVan Huysse, J.-
item.contributorMEBIS, Jeroen-
item.contributorAwada, A.-
item.contributorClaes, K. B. M.-
item.contributorHebrant, A.-
item.contributorVan der Meulen, J.-
item.contributorDelafontaine, B.-
item.contributorVanden Bempt, I-
item.contributorMaetens, J.-
item.contributorde Hemptinne, M.-
item.contributorRottey, S.-
item.contributorAftimos, P.-
item.contributorDe Greve, J.-
item.fulltextWith Fulltext-
item.accessRightsOpen Access-
crisitem.journal.eissn2059-7029-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
PRECISION_ the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.pdfPublished version822.84 kBAdobe PDFView/Open
Show simple item record

WEB OF SCIENCETM
Citations

4
checked on May 8, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.